Goldman Sachs’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Sell |
|
|||||
|
2025
Q1 | $6.73M | Buy |
|
|||||
|
2024
Q4 | $7.75M | Buy |
|
|||||
|
2024
Q3 | $5.63M | Buy |
|
|||||
|
2024
Q2 | $5.64M | Sell |
|
|||||
|
2024
Q1 | $18.8M | Buy |
|
|||||
|
2023
Q4 | $18.6M | Sell |
|
|||||
|
2023
Q3 | $12.6M | Sell |
|
|||||
|
2023
Q2 | $57.8M | Sell |
|
|||||
|
2023
Q1 | $43.7M | Sell |
|
|||||
|
2022
Q4 | $54.9M | Buy |
|
|||||
|
2022
Q3 | $65.4M | Buy |
|
|||||
|
2022
Q2 | $36.6M | Buy |
|
|||||
|
2022
Q1 | $25.4M | Buy |
|
|||||
|
2021
Q4 | $23.5M | Sell |
|
|||||
|
2021
Q3 | $33.7M | Buy |
|
|||||
|
2021
Q2 | $43.9M | Sell |
|
|||||
|
2021
Q1 | $48.2M | Buy |
|
|||||
|
2020
Q4 | $62.3M | Sell |
|
|||||
|
2020
Q3 | $40.2M | Buy |
|
|||||
|
2020
Q2 | $33.1M | Buy |
|
|||||
|
2020
Q1 | $17M | Buy |
|
|||||
|
2019
Q4 | $14.3M | Buy |
|
|||||
|
2019
Q3 | $8.78M | Sell |
|
|||||
|
2019
Q2 | $10.7M | Buy |
|
|||||
|
2019
Q1 | $3.85M | Buy |
|
|||||
|
2018
Q4 | $767K | Sell |
|
|||||
|
2018
Q3 | $1.3M | Buy |
|
|||||
|
2018
Q2 | $1.42M | Buy |
|